Quick Answer
MYRIAD GENETICS INC reported Revenue (ASC 606) of $824.50 million for fiscal year 2025.
MYRIAD GENETICS INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $824.50M | -1.6% |
| 2024 | $837.60M | +11.2% |
| 2023 | $753.20M | +11.0% |
| 2022 | $678.40M | -1.8% |
| 2021 | $690.60M | +24.0% |
| 2020 | $557.10M | -12.8% |
| 2020 | $638.60M | -25.0% |
| 2019 | $851.10M | +14.4% |
| 2018 | $743.70M | +2.1% |
| 2017 | $728.70M | -1.6% |
| 2016 | $740.50M | +2.5% |
| 2015 | $722.50M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $205.70M | -3.6% | -3.5% |
| June 30, 2025 | $213.10M | +0.8% | +8.8% |
| March 31, 2025 | $195.90M | -3.1% | -8.2% |
| September 30, 2024 | $213.30M | +11.2% | +0.9% |
| June 30, 2024 | $211.50M | +15.3% | +4.6% |
| March 31, 2024 | $202.20M | +11.6% | +5.4% |
| September 30, 2023 | $191.90M | +22.7% | +4.6% |
| June 30, 2023 | $183.50M | +2.3% | +1.3% |
- MYRIAD GENETICS INC showed a decrease of -1.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2015–2025 period, MYRIAD GENETICS INC’s revenue (asc 606) has grown by 14.1% (from $722.50 million to $824.50 million).
- The most recent figure is from MYRIAD GENETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: